ELEVATED PLASMA TGF-β1 IN RENAL DISEASES: CAUSE OR CONSEQUENCE?

This publication has 15 references indexed in Scilit:

• TGF-β1 alters the healing of cutaneous fetal excisional wounds
  Journal of Pediatric Surgery, 1999
• Elevated serum levels of transforming growth factor-?1 in patients with colorectal carcinoma
  Cancer, 1999
• Role of Transforming Growth Factor-β1 in Invasion and Metastasis in Gastric Carcinoma
  Journal of Clinical Oncology, 1999
• Aggregating Human Platelets Stimulate the Expression of Thrombin Receptors in Cultured Vascular Smooth Muscle Cells via the Release of Transforming Growth Factor-β ₁ and Platelet-Derived Growth Factor _AB
  Circulation, 1997
• Serum Transforming Growth Factor-beta 1 in Patients With Renal Cell Carcinoma
  Journal of Urology, 1997
• Renal Cell Carcinomas Produce IL-6, IL-10, IL-11, and TGF-β1 in Primary Cultures and Modulate T Lymphocyte Blast Transformation
  Journal of Interferon & Cytokine Research, 1997
• Transforming Growth Factor Beta 1 is Significantly Elevated in Plasma of Patients Suffering from Renal Cell Carcinoma
  Cytokine, 1996
• Transforming Growth Factor β₁Inhibits Interleukin-10 mRNA Expression and Production in Pokeweed Mitogen-Stimulated Peripheral Blood Mononuclear Cells and T Cells
  Journal of Interferon & Cytokine Research, 1995
• Transforming growth factor-β1 (TGF-β1) inhibits DNA synthesis of PWM-stimulated PBMC via suppression of IL-2 and IL-6 production
  Cytokine, 1994
• Selective depression of T‐lymphocyte subsets in gastric cancer patients: An implication of immunotherapy
  Journal of Surgical Oncology, 1994